BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA): 'Commercial Precedents Continue to Read Through Positively to ORKA-001/2'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. SPY
4. IQMX
5. EROC
6. MSTR
7. NVDA
8. TSLA
9. MSFT
10. SEER

Go back to BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA): 'Commercial Precedents Continue to Read Through Positively to ORKA-001/2'
(NASDAQ: ORKA) Delayed: 83.93 -1.28 (1.5%)
Previous Close $85.21    52 Week High $ 
Open $83.68    52 Week Low $ 
Day High $85.73    P/E N/A 
Day Low $82.90    EPS $ 
Volume 977,949